Shedir Pharma Group SpA is a holding company, which engages in the research and development of nutraceuticals and medical devices. It operates through the BU1 and BU2 business units. The BU1 unit focuses on the development, formulation, promotion, and marketing of nutraceuticals, dermocosmetics, and medical equipment. The BU2 unit specializes in the production and distribution of medicines and other pharmaceuticals. The company was founded by Umberto di Maio on October 13, 2014 and is headquartered in Piano di Sorrento, Italy.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company